Actively Recruiting
Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2026-03-02
264
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The "COME ON, NOW!" trial is a randomized, single-center trial in patients recovering from non-cardiac surgery on normal wards investigating whether continuous vital sign monitoring - compared to routine spot-checks by nurses - reduces the total duration of abnormal vital signs per hour during the first 48 hours after admission to the normal ward.
CONDITIONS
Official Title
Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consenting patients aged 45 years or older scheduled for elective non-cardiac abdominal or thoracic surgery
- Planned postoperative admission to a normal ward after an overnight stay in an advanced post-anesthesia care unit
You will not qualify if you...
- Emergency surgery
- Pregnancy
- Inability to perform continuous monitoring with the Radius VSM sensor
- Presence of atrial fibrillation
- Patients designated Do Not Resuscitate or receiving end-of-life care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany, 20251
Actively Recruiting
Research Team
K
Kristen K Thomsen, MD
CONTACT
S
Simon Stemmler, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here